Commercial fibrin sealants are not equivalent in a rabbit liver-resection model which quantitatively evaluates hemostasis and formation of adhesions

European Surgical Research

Volumn 37, Issue 3, 2005, Pages 159-165

  Nur, I ^a,d   Lyahovetsky, Y ^b   Bar, L ^a   Schon, M ^c  

^a Omrix Biopharmaceuticals SA   (Belgium)

^b ASSAF HAROFEH MEDICAL CENTER   (Israel)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d Omrix Biopharmaceuticals Ltd   (Israel)

Author keywords

Adhesions; Animal model, rabbit; Cryoprecipitate; Fibrin sealant; Fibrinogen; Fibrinolysis; Hemostasis; Heparin; Liver resection; Thrombin

Indexed keywords

FIBRIN GLUE; HEPARIN; QUIXIL;

ADHESION; ANIMAL EXPERIMENT; ARTICLE; BLEEDING; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; HEMOSTASIS; LIVER RESECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT;

ADHESIONS; AEROSOLS; ANIMALS; BLOOD LOSS, SURGICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRIN TISSUE ADHESIVE; HEMOSTASIS, SURGICAL; HEMOSTATICS; HEPARIN; HEPATECTOMY; MODELS, ANIMAL; OSMOLAR CONCENTRATION; PARTIAL THROMBOPLASTIN TIME; RABBITS; THROMBIN;

EID: 23844485711     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085963     Document Type: Article

References (11)

1. Mankad PS, Codispoti M: The role of fibrin sealants in hemostasis. Am J Surg 2001;182:21S-28S.
2. Jackson MR: Fibrin sealants in surgical practice: an overview. Am J Surg 2001;182(suppl 2):1S-7S.
3. Radosevich M, Goubran HA, Burnouf T: Fibrin sealant: Scientific rationale, production methods, properties, and current clinical use. Vox Sang 1997;72:133-143.
4. Sheppard BB, Devirgilio C, Bleiweis M, Millikin JC, Robertson JM: Inhibition of intra-abdominal adhesions: Fibrin glue in a long term model. Am Surg 1993;59:786-790.
5. Kheirabadi BS, Pearson R, Rudnicka K, Somwaru L, MacPhee M, Drohan W, Tuthill D: Development of an animal model for assessment of the hemostatic efficacy of fibrin sealant in vascular surgery. J Surg Res 2001;100:84-92.
6. Martinowitz U, Varon D, Heim M: The role of fibrin tissue adhesives in surgery of haemophilia patients. Haemophilia 1998;4:443-448.
7. Dickneite G, Metzner H, Pfeifer T, Kroez M, Witzke G: A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res 2003;112:73-82.
8. Carrie D, Caranobe C, Saivin S, Houin G, Petitou M, Lormeau JC, Van Boeckel C, Meuleman D, Boneu B: Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: Comparison with CY216. Blood 1994;84:2571-2577.
9. Wiseman D, Lyachovetsky Y, Keidan I, Trout JR, Nur I: The effect of tranexamic acid in fibrin sealant on adhesion formation in the rat. J Biomed Mater Res 2004;68B:222-230.
10. Bussuttil RW: A comparison of antifibrinolytic agents used in hemostatic fibrin sealants. J Am Coll Surg 2003;197:1021-1028.
11. Nur I, Routledge L, Lushkov G, Paulmier P, Virat M: Absorption and elimination of alpha-thrombin and tranexamic acid after fibrin sealant application on resected livers in rabbits. Blood Coagul Fibrinolysis 1998;9:533-537.